Several studies have demonstrated the importance of memory T cell subsets in immunotherapy responses in cancer and viral immunity (1, 34, 47), so we examined their distribution in CD8+ T cells derived from a stage IV metastatic breast cancer patient treated with paclitaxel/trastuzumab/pertuzumab followed by in vitro phenelzine treatment. The gene discussed is CD8A; the disease is cancer.